Argenx
ARGX
#436
Rank
โ‚น4.814 T
Marketcap
โ‚น77,312
Share price
-0.63%
Change (1 day)
42.63%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น800.54. In 2024 the company made an earnings per share (EPS) of โ‚น1,256 an increase over its 2023 EPS that were of -โ‚น465.70.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-38.17%
2024โ‚น1,256-369.77%
2023-โ‚น465.70-60.46%
2022-โ‚น1,17863.33%
2021-โ‚น721.11-40.37%
2020-โ‚น1,209183.47%
2019-โ‚น426.63123.09%
2018-โ‚น191.2454.93%
2017-โ‚น123.4314.07%
2016-โ‚น108.2113.05%
2015-โ‚น95.71-36.34%
2014-โ‚น150.35209.04%
2013-โ‚น48.65-33.99%
2012-โ‚น73.70185.59%
2011-โ‚น25.81